Bellerophon Therapeutics, Inc. Operating Lease Right-of-Use Assets
Bellerophon Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $0 as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-11-14
- 2023-09-30: Operating Lease, Right-of-Use Asset $0.00.
- 2023-06-30: Operating Lease, Right-of-Use Asset $0.00.
- 2023-03-31: Operating Lease, Right-of-Use Asset $8.00K.
- 2022-12-31: Operating Lease, Right-of-Use Asset $184.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $8.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $184.00K 10-Q · filed 2023-11-14 |
| 2022-09-30 | $357.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $529.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $697.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $863.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.03M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.19M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.35M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.50M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.66M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.81M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.96M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.11M 10-K · filed 2021-03-11 |
| 2019-09-30 | $2.26M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.06M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.19M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $2.30M 10-Q · filed 2019-11-06 |
| 2018-12-31 | $0.00 10-K · filed 2020-04-06 |